Abstract
miR-363-3p has been shown to suppress tumor growth and metastasis in various human cancers. However, the function of miR-363-3p in osteosarcoma (OS) has not been determined. In our study, we found that the expression of miR-363-3p was significantly downregulated in OS tissues compared with adjacent normal tissues. miR-363-3p expression was associated with the poor overall survival rate of OS patients. Moreover, we found that overexpression of miR-363-3p markedly inhibited the proliferation, migration, and invasion of U2OS and MG63 cells. Moreover, we found that SOX4 was a direct target of miR-363-3p in OS cells. Overexpression of miR-363-3p significantly inhibited the expression of SOX4. Expression levels of miR-363-3p and SOX4 were negatively correlated in OS tissues. Finally, we found that restoration of SOX4 attenuated the suppressive effects of miR-363-3p on the proliferation, migration, and invasion of U2OS and MG63 cells. Therefore, our findings demonstrated that miR-363-3p served as a tumor suppressor in OS tissues by targeting SOX4.
References
Jan 28, 2004·Cell·David P Bartel
Jun 16, 2009·Japanese Journal of Clinical Oncology·Po Kuei WuTain Hsiung Chen
Mar 10, 2010·Cancer Treatment and Research·Giulia Ottaviani, Norman Jaffe
Dec 19, 2012·The International Journal of Biochemistry & Cell Biology·Qiang SunWantao Chen
May 9, 2014·PloS One·Desiree Hunt FloydBenjamin W Purow
Sep 10, 2015·International Journal of Oncology·Yulong LiuQingsan Zhu
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 17, 2016·Biochemical and Biophysical Research Communications·Fayong HuXiaolan Li
May 12, 2016·Oncotarget·Peng-Fei ZhangJin-Shui Zhu
Jun 14, 2016·Biochemistry. Biokhimii︠a︡·N E KushlinskiiE A Braga
Apr 21, 2017·Oncotarget·Yahong WangGang Liu
Aug 3, 2017·Molecular Medicine Reports·Xiaolin WuXuexiao Ma
Oct 11, 2017·Molecular Medicine Reports·Wei YuanZhongliang Deng
Oct 20, 2017·Oncology Reports·Qingchun CaiWei Ma
Oct 21, 2017·Scientific Reports·Yang LiuBing-Shan Liu
Nov 25, 2017·Biochemical and Biophysical Research Communications·Zhe Han, Liying Shi
Nov 29, 2017·Oncotarget·Ye-Bin LuQi Zhang
Dec 20, 2017·Oncotarget·Yang LinManhua Cui
Jan 7, 2018·BMC Cancer·Bin ZengGao Tan
Citations
Jul 25, 2019·Journal of Cellular Physiology·Jingxia ChangYibing Chen
Jul 2, 2019·Acta Biochimica Et Biophysica Sinica·Yi PanYu Chen
Jan 23, 2020·Thoracic Cancer·Hao RongJintao He
Jul 4, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Zhijuan YuXiujuan Li
May 3, 2020·World Journal of Surgical Oncology·Yongtao ZhangQuanbin Zhang
Oct 17, 2019·Frontiers in Genetics·Christopher M SmithGyorgy Hutvagner
Jan 13, 2021·Biochemical Genetics·Xiuming LiuJianchang Li
Feb 10, 2021·Cell Death Discovery·Na JiangLei Shang
Mar 21, 2021·Journal of Bioenergetics and Biomembranes·Qianqian GengNanzheng Chen
Oct 16, 2020·Journal of the National Cancer Institute·Xinyi LiuXiaowei Wang
Jun 30, 2021·Clinical and Translational Medicine·Li ShijieCheng Dongdong
Sep 22, 2021·Clinical and Experimental Pharmacology & Physiology·Qiwen PanYueqing Li